Related Experiment Video
Updated: May 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Alliance against MDRO: safeguarding antibiotics]
Abstract:
Resistance to antibiotics has increased recently to a dramatic extend, and the pipeline of new antibiotics is almost dry for the 5 next years. Failures happen already for trivial community acquired infections, like pyelonephritis, or peritonitis, and this is likely to increase. Difficult surgical procedures, transplants, and other immunosuppressive therapies will become far more risky. Resistance is mainly due to an excessive usage of antibiotics, in all sectors, including the animal one. Action is urgently needed. Therefore, an alliance against MDRO has been recently created, which includes health care professionals, consumers, health managers, and politicians. The document highlights the different proposed measures, and represents a strong consensus between the different professionals, including general practitioners, and veterinarians.
Insights
Antibiotic resistance is a growing crisis with few new drugs available. An alliance of professionals and policymakers is urgently needed to combat multidrug-resistant organisms (MDROs).
Area of Science:
- Microbiology
- Public Health
- Pharmacology
Context:
- Escalating antibiotic resistance poses a significant threat to global health.
- The current pipeline for new antibiotics is critically insufficient to meet future demands.
- Existing treatments are failing for common infections, increasing risks for complex medical procedures.
Purpose:
- To highlight the urgent need for action against multidrug-resistant organisms (MDROs).
- To introduce a newly formed alliance dedicated to combating antibiotic resistance.
- To outline proposed measures and emphasize professional consensus.
Summary:
- Antibiotic resistance is dramatically increasing, with a severe shortage of new antibiotics expected.
- Excessive antibiotic use across human and animal sectors drives this resistance.
- An alliance involving healthcare professionals, consumers, managers, and politicians has formed to address MDROs.
Impact:
- Increased risk for surgeries, transplants, and immunosuppressive therapies.
- Potential for common infections to become untreatable.
- Urgent need for coordinated action and policy changes to preserve antibiotic efficacy.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Antibiotic Selection
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Effectiveness
